Biotech

All Articles

Vaccine and Keytruda combination effective in squamous cell carcinoma

.Immune gate inhibitors are the superheroes of cancer treatment. Medications like Bristol Myers Squi...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of considerable leadership hirings, firings...

Regeneron's Opdualag rival shows 57% action fee

.Regeneron is actually back with lasting consequence for its LAG-3 prevention and also PD-1 inhibito...

AstraZeneca blog posts data on in-house opponents to AbbVie, Pfizer ADCs

.AstraZeneca has actually discussed a very early take a look at the efficiency of its in-house antib...

iTeos- GSK's TIGIT star presents significant renovation

.After introducing a stage 3 launch based on beneficial midstage results, iTeos and also GSK are las...

More collective FDA can accelerate uncommon illness R&ampD: record

.The FDA needs to be much more available and collective to discharge a rise in approvals of rare dis...

Zenas, MBX, Bicara head to Nasdaq in hot time for biotech IPOs

.It's an abnormally active Friday for biotech IPOs, along with Zenas BioPharma, MBX as well as Bicar...

Atea's COVID antiviral stops working to stop hospitalizations in phase 3

.Atea Pharmaceuticals' antiviral has neglected one more COVID-19 trial, yet the biotech still keeps ...

Neurocrine's proposal to spare schizophrenia prospect stops working

.Neurocrine Biosciences' mental illness system pivot has failed. The biotech was not able to duplica...

Sanofi pays out $110M upfront for late-stage radioligand treatment

.Sanofi has actually created a late entry to the radioligand party, paying out 100 million europeans...